[Federal Register Volume 87, Number 161 (Monday, August 22, 2022)]
[Notices]
[Page 51437]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-18000]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute of Allergy and Infectious Diseases; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The contract proposals and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Allergy and Infectious 
Diseases, Special Emphasis Panel; Development of Medical 
Countermeasures for Biothreat Agents, Antimicrobial-Resistant 
Infections and Emerging Infectious Diseases; Research Area 002--
Development of Therapeutic Candidates for Biodefense, Antimicrobial 
Resistant (AMR) Infect.
    Date: September 7-8, 2022.
    Time: 10 a.m. to 2 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3E70, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Mohammed S. Aiyegbo, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3E70, 
Rockville, MD 20852, (301) 761-7106, [email protected].

    Name of Committee: National Institute of Allergy and Infectious 
Diseases, Special Emphasis Panel; NIAID 2022 Omnibus BAA (HHS-NIH-
NIAID-BAA2022-1) Research Area 002: Development of Therapeutic 
Candidates for Biodefense, Antimicrobial Resistant (AMR) Infections 
and Emerging Infectious Diseases (N01).
    Date: September 13-14, 2022.
    Time: 10 a.m. to 5 p.m.
    Agenda: To review and evaluate contract proposals.
    Place: National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3E70, 
Rockville, MD 20892 (Virtual Meeting).
    Contact Person: Mohammed S. Aiyegbo, Ph.D., Scientific Review 
Officer, Scientific Review Program, Division of Extramural 
Activities, National Institute of Allergy and Infectious Diseases, 
National Institutes of Health, 5601 Fishers Lane, Room 3E70, 
Rockville, MD 20852, (301) 761-7106, [email protected].

(Catalogue of Federal Domestic Assistance Program Nos. 93.855, 
Allergy, Immunology, and Transplantation Research; 93.856, 
Microbiology and Infectious Diseases Research, National Institutes 
of Health, HHS)

    Dated: August 16, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-18000 Filed 8-19-22; 8:45 am]
BILLING CODE 4140-01-P